| Antibody . | MAYV . | UNAV . | CHIKV . | RRV . | ONNV . |
|---|---|---|---|---|---|
| MAY-115 | + | + | − | − | − |
| MAY-116 | + | + | + | − | − |
| MAY-117 | + | + | + | + | − |
| MAY-118 | + | + | + | − | − |
| MAY-119 | + | + | + | − | − |
| MAY-120 | + | + | + | + | − |
| MAY-121 | + | + | + | + | − |
| MAY-122 | + | + | − | − | − |
| MAY-125 | + | + | + | − | − |
| MAY-130 | + | + | + | − | + |
| MAY-131 | + | + | − | − | − |
| MAY-133 | + | + | − | − | − |
| MAY-134 | + | + | − | − | − |
| MAY-139 | + | − | − | − | − |
| MAY-140 | + | − | − | − | − |
| MAY-146 | + | + | + | − | − |
| MAY-147 | + | + | − | − | − |
| MAY-151 | + | + | + | − | − |
| Antibody . | MAYV . | UNAV . | CHIKV . | RRV . | ONNV . |
|---|---|---|---|---|---|
| MAY-115 | + | + | − | − | − |
| MAY-116 | + | + | + | − | − |
| MAY-117 | + | + | + | + | − |
| MAY-118 | + | + | + | − | − |
| MAY-119 | + | + | + | − | − |
| MAY-120 | + | + | + | + | − |
| MAY-121 | + | + | + | + | − |
| MAY-122 | + | + | − | − | − |
| MAY-125 | + | + | + | − | − |
| MAY-130 | + | + | + | − | + |
| MAY-131 | + | + | − | − | − |
| MAY-133 | + | + | − | − | − |
| MAY-134 | + | + | − | − | − |
| MAY-139 | + | − | − | − | − |
| MAY-140 | + | − | − | − | − |
| MAY-146 | + | + | + | − | − |
| MAY-147 | + | + | − | − | − |
| MAY-151 | + | + | + | − | − |
Vero cells infected with the indicated alphavirus were incubated with anti-MAYV mAbs. Binding to infected cells was determined by flow cytometry. Data are representative of two experiments performed in triplicate. + indicates cross-reactive and − indicates non–cross-reactive.